LIPOPROTEIN(A) LEVELS IN NAFLD PATIENTS: A NOVEL BIOMARKER TO PREDICT HEPATIC FIBROSIS

被引：0
|
作者：
Meroni, Marica [1 ]
Longo, Miriam [1 ,2 ]
Lombardi, Rosa [3 ,4 ]
Paolini, Erika [5 ]
Macchi, Chiara [6 ]
Corsini, Alberto [6 ]
Sirtori, Cesare [6 ]
Fracanzani, Anna Ludovica [7 ]
Ruscica, Massimiliano [6 ]
Dongiovanni, Paola [1 ]
机构：
[1] Fdn Irccs Ca Granda Osped Maggiore Policlin, Gen Med & Metab Dis, Milan, Italy
[2] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
[3] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy
[4] Fdn Irccs Ca Granda Osped Maggiore Policlin, Unit Internal Med & Metab Dis, Milan, Italy
[5] Fdn Irccs Ca Granda Osped Maggiore Policlin, Milan, Italy
[6] Univ Milan, Milan, Italy
[7] Univ Milan, Dept Pathophysiol & Transplantat, Unit Internal Med & Metab Dis, Policlin Hosp,Ca Granda Irccs Fdn, Milan, Italy
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1873
引用
收藏
页码：1114A / 1114A
页数：1
相关论文
共 50 条
  • [41] PROC3 DERIVED SCORES FOR LIVER FIBROSIS PREDICT CARDIOVASCULAR EVENTS IN NAFLD PATIENTS
    Baratta, F.
    Pastori, D.
    Tozzi, G.
    Colanotni, A.
    Cocomello, N.
    Cecchi, S.
    Coronati, M.
    Angelico, F.
    Del Ben, M.
    ATHEROSCLEROSIS, 2022, 355 : E80 - E80
  • [42] Management of NAFLD patients with advanced fibrosis
    Maya-Miles, Douglas
    Ampuero, Javier
    Gallego-Duran, Rocio
    Dingianna, Paola
    Romero-Gomez, Manuel
    LIVER INTERNATIONAL, 2021, 41 : 95 - 104
  • [43] A serum metabolic fingerprint may predict advanced fibrosis due to NAFLD in a cohort of diabetic patients
    Forlano, Roberta
    Mullish, Benjamin H.
    Blanco, Jesus Miguens
    Danckert, Nathan
    Thursz, Mark
    Manousou, Pinelopi
    JOURNAL OF HEPATOLOGY, 2021, 75 : S540 - S540
  • [44] STAGING OF LIVER FIBROSIS WITH ULTRASOUND MORPHOLOGICAL HEPATIC FEATURES IN PATIENTS AFFECTED BY HCV HEPATITIS AND NAFLD
    Ziola, S.
    Picciotto, A.
    Labanca, S.
    Marenco, S.
    Trombini, M.
    Dellepiane, S.
    Pasta, A.
    Sheijani, Djahandideh A.
    Pisciotta, L.
    Borro, P.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S165 - S166
  • [45] Is the grade of ballooned hepatocytes a significant risk factor for rapid progression of hepatic fibrosis in patients with NAFLD?
    Sumida, Yoshio
    Yoneda, Masashi
    Okanoue, Takeshi
    JOURNAL OF GASTROENTEROLOGY, 2019, 54 (05) : 474 - 475
  • [46] Advancement of hepatic fibrosis among general women with/without NAFLD
    Ibusuki, R.
    Shimoshikiryo, I.
    Shimatani, K.
    Nishimoto, D.
    Maenohara, S.
    Takezaki, T.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2019, 29 : 358 - 358
  • [47] The diagnostic accuracy of non-invasive serum biomarkers for hepatic fibrosis in a cohort of patients with NAFLD
    Pecoraro, V.
    Cuccorese, M.
    Gabrielli, F.
    Andreone, P.
    Nascimbeni, F.
    Trenti, T.
    CLINICA CHIMICA ACTA, 2024, 558 : 76 - 76
  • [48] NOVEL MACHINE LEARNING MODEL TO PREDICT NASH IN NAFLD PATIENTS WITH DIABETES MELLITUS
    Aggarwal, Manik
    Singh, Amandeep
    Bansal, Agam
    McCullough, Arthur J.
    HEPATOLOGY, 2020, 72 : 932A - 933A
  • [49] Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?
    McPherson, Stuart
    Anstee, Quentin M.
    Henderson, Elsbeth
    Day, Christopher P.
    Burt, Alastair D.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (06) : 652 - 658
  • [50] Steatohepatitis and Advanced Fibrosis in NAFLD Patients with Normal Aminotransferases Levels: Prevalence and Clinical features
    Gawrieh, Samer
    Wilson, Laura
    Cummings, Oscar
    Kowdley, Kris V.
    Sanyal, Arun J.
    Clark, Jeanne M.
    Doo, Edward
    Kleiner, David E.
    Tonascia, James
    Chalasani, Naga P.
    HEPATOLOGY, 2017, 66 : 1169A - 1169A
12345